Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 813

1.

Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma.

Fang JM, Arlt MF, Burgess AC, Dagenais SL, Beer DG, Glover TW.

Genes Chromosomes Cancer. 2001 Mar;30(3):292-8.

PMID:
11170287
2.
4.

Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas.

Michael D, Beer DG, Wilke CW, Miller DE, Glover TW.

Oncogene. 1997 Oct 2;15(14):1653-9.

5.

Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene.

Popovici C, Basset C, Bertucci F, Orsetti B, Adélaide J, Mozziconacci MJ, Conte N, Murati A, Ginestier C, Charafe-Jauffret E, Ethier SP, Lafage-Pochitaloff M, Theillet C, Birnbaum D, Chaffanet M.

Genes Chromosomes Cancer. 2002 Nov;35(3):204-18.

PMID:
12353263
6.

FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.

Fong KM, Biesterveld EJ, Virmani A, Wistuba I, Sekido Y, Bader SA, Ahmadian M, Ong ST, Rassool FV, Zimmerman PV, Giaccone G, Gazdar AF, Minna JD.

Cancer Res. 1997 Jun 1;57(11):2256-67.

7.

Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene.

Zimonjic DB, Druck T, Ohta M, Kastury K, Croce CM, Popescu NC, Huebner K.

Cancer Res. 1997 Mar 15;57(6):1166-70.

8.

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.

Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K.

Cell. 1996 Feb 23;84(4):587-97.

9.

A novel approach to simultaneously scan genes at fragile sites.

Willem P, Brown J, Schouten J.

BMC Cancer. 2006 Aug 8;6:205.

10.

Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.

Ahmadian M, Wistuba II, Fong KM, Behrens C, Kodagoda DR, Saboorian MH, Shay J, Tomlinson GE, Blum J, Minna JD, Gazdar AF.

Cancer Res. 1997 Sep 1;57(17):3664-8.

11.

FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.

Bugert P, Wilhelm M, Kovacs G.

Genes Chromosomes Cancer. 1997 Sep;20(1):9-15.

PMID:
9290948
12.

The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region.

Glover TW, Hoge AW, Miller DE, Ascara-Wilke JE, Adam AN, Dagenais SL, Wilke CM, Dierick HA, Beer DG.

Cancer Res. 1998 Aug 1;58(15):3409-14.

13.

Expression of aberrant functional and nonfunctional transcripts of the FHIT gene in Burkitt's lymphomas.

Ferrer M, López-Borges S, Lazo PA.

Mol Carcinog. 1999 May;25(1):55-63.

PMID:
10331745
14.

Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion.

Inoue H, Ishii H, Alder H, Snyder E, Druck T, Huebner K, Croce CM.

Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14584-9.

15.

Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells.

Arlt MF, Miller DE, Beer DG, Glover TW.

Genes Chromosomes Cancer. 2002 Jan;33(1):82-92.

PMID:
11746990
16.

Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B.

Boldog F, Gemmill RM, West J, Robinson M, Robinson L, Li E, Roche J, Todd S, Waggoner B, Lundstrom R, Jacobson J, Mullokandov MR, Klinger H, Drabkin HA.

Hum Mol Genet. 1997 Feb;6(2):193-203.

17.

Induction of the common fragile site FRA3B does not affect FHIT expression.

Michael D, Rajewsky MF.

Oncogene. 2001 Mar 29;20(14):1798-801.

18.

Common fragile sites and cancer (review).

Smith DI, Huang H, Wang L.

Int J Oncol. 1998 Jan;12(1):187-96. Review.

PMID:
9454904
19.

FRA3B and other common fragile sites: the weakest links.

Huebner K, Croce CM.

Nat Rev Cancer. 2001 Dec;1(3):214-21.

PMID:
11902576
20.

Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer: association with human papillomavirus type.

Muller CY, O'Boyle JD, Fong KM, Wistuba II, Biesterveld E, Ahmadian M, Miller DS, Gazdar AF, Minna JD.

J Natl Cancer Inst. 1998 Mar 18;90(6):433-9.

Items per page

Supplemental Content

Write to the Help Desk